Cargando…
Effect of Hypertension on Outcomes of High-Risk Patients After BCG-Treated Bladder Cancer: A Single-Institution Long Follow-Up Cohort Study
Immunotherapy with Bacillus Calmette–Guérin (BCG) is the most efficacious treatment for high-risk bladder cancer (BC) (Ta/T1 or carcinoma in situ) to reduce the risk of recurrence. Our aim was to evaluate whether hypertension and diabetes influence the outcome of patients with noninvasive BC treated...
Autores principales: | Dal Moro, Fabrizio, Bovo, Alberto, Crestani, Alessandro, Vettor, Roberto, Gardiman, Marina P., Zattoni, Filiberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553954/ https://www.ncbi.nlm.nih.gov/pubmed/25738480 http://dx.doi.org/10.1097/MD.0000000000000589 |
Ejemplares similares
-
Definitive BCG immunotherapy versus radical cystectomy in intermediate or high-risk nonmuscle invasive bladder cancer patients: A retrospective study
por: Jian, Xiaoming, et al.
Publicado: (2019) -
Endourologic Diagnosis and Robotic Treatment of a Giant Fibroepithelial Polyp of the Ureter
por: Cattaneo, Francesco, et al.
Publicado: (2016) -
The Role of Lymph Node Dissection in the Treatment of Bladder Cancer
por: Cattaneo, Francesco, et al.
Publicado: (2018) -
Follow-up care of 12 months of patients with bladder cancer in Spain: A multicenter prospective cohort study
por: Bonfill, Xavier, et al.
Publicado: (2022) -
Deceptive Muscle Invasive Bladder Cancer Recurrence With Benign Biopsy Foci After Bladder Sparing Treatment
por: Xu, Chuanliang, et al.
Publicado: (2015)